| Half-life | 6 hours |
| Tmax | 3 h |
| Bioavailability | 60 % (approx) |
| Protein Binding | 0 % |
| Volume of Distribution | 0.6 L/kg (approx) |
| Clearance Route | renal |
| Active Metabolites | no |
| Notes | Absorption saturable—bioavailability decreases with higher doses. |
Severity: Moderate
Adverse Effects:
Sedation, dizziness, peripheral edema
Contraindications:
Severe renal failure
Precautions:
Reduce dose in renal impairment; avoid alcohol/CNS depressants